Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Helmholtz Institute for Translational Oncology Mainz - A Helmholtz Institute of the DKFZ

Immunotherapy has revolutionized the treatment of some types of cancer in recent years. But the sometimes spectacular healing successes are facing numerous patients who do not benefit from the treatment. Why this is and how to remedy this is one of the most pressing questions of cancer research. The Helmholtz Institute for Translational Oncology Mainz (HI-TRON Mainz) takes up this question in order to develop pioneering personalized immuno-therapy for cancer therapy based on a deep understanding of the mechanisms of action. For this reason, the goal of HI-TRON Mainz is to achieve a real breakthrough in cancer therapy with these pioneering immunotherapies.

At the Helmholtz Institute for Translational Oncology Mainz (HI-TRON Mainz), the German Cancer Research Center cooperates with the Research Institute for Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz (TRON gGmbH), the University Medical Center Mainz and the Johannes Gutenberg University Mainz in order to combine the internationally outstanding expertise of the partners in the field of personalized immunotherapy with the translational top research in the DKFZ. The new Helmholtz Institute for Translational Oncology (HI-TRON) is to be set up as a world-leading center for personalized cancer medicine with a focus on immunotherapy at the science location Mainz. The cooperation partners of HI-TRON Mainz want to pursue this goal together, so that in future even more patients can benefit from the powerful weapon against cancer.

With the establishment of the HI-TRON Mainz, an institute will be created that strongly links the two locations and which will become a center of excellence in translational oncology. Through its institutionalized academic format in collaboration with industry, HI-TRON Mainz will expand the global reputation of both sites as a biotechnology hotspot and bring new therapies to clinical translation as quickly as possible.

Contact Person:
Dr. Julia Neuhaus
Administrative Coordination
Helmholtz Institute for Translational Oncology Mainz (HI-TRON Mainz)

Phone: +49 6131 179829
Mobile: : +49 174 37 59 426

In Heidelberg:
Im Neuenheimer Feld 280
69120 Heidelberg

In Mainz:
Obere Zahlbacher Str. 63
55131 Mainz

to top
powered by webEdition CMS